• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [15923 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2014 Haute Autorite de sante (HAS) [Assessment of real-time optical endomicroscopy performed during mapping of Barrett's esophagus (BE) (for diagnosis of BE-associated early neoplasia)]
2014 Haute Autorite de sante (HAS) [Detection of enterovirus genome in cerebrospinal fluid by gene amplification in meningitis patients]
2014 Haute Autorite de sante (HAS) [Assessment of the risks associated with aesthetic mesotherapy practices]
2014 Haute Autorite de sante (HAS) [Elements to evaluate for managing a patient in outpatient surgery]
2014 Haute Autorite de sante (HAS) [Assessment of non-invasive methods for measuring liver fibrosis in chronic hepatitis B. Initial assessment and follow-up of non-treated adult patients]
2014 Haute Autorite de sante (HAS) [Assessment of spinal cord stimulation]
2014 Haute Autorite de sante (HAS) [Ultrasound guidance for peripheral nerve blockade]
2014 Malaysian Health Technology Assessment (MaHTAS) Rapid blood test device for HIV, HBV, HCV, & syphillis
2014 Malaysian Health Technology Assessment (MaHTAS) Ultrasonic wound debridement device
2014 Malaysian Health Technology Assessment (MaHTAS) Pulse oximetry screening for critical congenital heart disease in newborn infants
2014 Malaysian Health Technology Assessment (MaHTAS) Piston-type mechanical chest compression
2014 Malaysian Health Technology Assessment (MaHTAS) Inexscreen as a screening test for ectopic pregnancy and miscarriage
2014 Malaysian Health Technology Assessment (MaHTAS) Extracorporeal Shockwave Myocardial Revascularization (ESMR)
2014 Malaysian Health Technology Assessment (MaHTAS) T.SPOT.TB assay – an update
2014 Malaysian Health Technology Assessment (MaHTAS) Computer assisted surgery for unicondylar and total knee replacement
2014 Malaysian Health Technology Assessment (MaHTAS) Acupuncture for chemotherapy-induced nausea and vomiting in cancer patients
2014 Malaysian Health Technology Assessment (MaHTAS) Pneumococcal conjugate vaccine for children below five years old
2014 Malaysian Health Technology Assessment (MaHTAS) Continuous intrathecal baclofen (ITB) infusion for severe spasticity and dystonia
2014 Malaysian Health Technology Assessment (MaHTAS) Bronchial thermoplasty
2014 Malaysian Health Technology Assessment (MaHTAS) Screening of pregnant women aged 40 years old and above for cardiac abnormalities using electrocardiography (ECG) to prevent maternal mortality
2014 Malaysian Health Technology Assessment (MaHTAS) OncoE6TM cervical screening test kit
2014 Malaysian Health Technology Assessment (MaHTAS) Infrared regulation thermography for cancer
2014 Malaysian Health Technology Assessment (MaHTAS) Effect of promoting formula milk for toddler, and pregnant as well as breastfeeding mothers on the breastfeeding practice
2014 Malaysian Health Technology Assessment (MaHTAS) Enercel homeopathic medicine for patient with infectious diseases and motor neuron disease
2014 Malaysian Health Technology Assessment (MaHTAS) Cone beam computed tomography
2014 Malaysian Health Technology Assessment (MaHTAS) Typhoid carrier test (Typhidot-C)
2014 Malaysian Health Technology Assessment (MaHTAS) Colorec bowel aid with Hai's Perianal Support (HPS)
2014 Malaysian Health Technology Assessment (MaHTAS) Antimicrobial dressing with Activated Carbon Fibre (ACF)
2014 New Zealand National Health Committee (NHC) Varicella and rotovirus vaccination in New Zealand - assessment reports
2014 New Zealand National Health Committee (NHC) Ischaemic heart disease: a pathway to prioritisation
2014 New Zealand National Health Committee (NHC) Chronic obstructive pulmonary disease: a pathway to prioritisation
2014 The Regional Health Technology Assessment Centre (HTA-centrum) Bariatric surgery in adolescents with severe obesity
2014 The Regional Health Technology Assessment Centre (HTA-centrum) Robotically assisted laparoscopic surgery for rectal cancer
2014 The Regional Health Technology Assessment Centre (HTA-centrum) Left Ventricular Assist Device as permanent support in patients with end-stage heart failure
2014 The Regional Health Technology Assessment Centre (HTA-centrum) Orthodontic retainers
2014 The Regional Health Technology Assessment Centre (HTA-centrum) Pediatric robotically assisted surgery for pyeoloplasty and fundoplication
2014 The Regional Health Technology Assessment Centre (HTA-centrum) Home-based versus hospital-based supervised exercise or walk advice as treatment for intermittent claudication
2014 The Regional Health Technology Assessment Centre (HTA-centrum) Botulinum toxin type A for prophylactic treatment of chronic migraine
2014 The Regional Health Technology Assessment Centre (HTA-centrum) Psychological interventions to improve poor oral health in adults and adolescents
2014 The Regional Health Technology Assessment Centre (HTA-centrum) Invasive ventilation in patients with Amyotrophic Lateral Sclerosis and respiratory failure
2014 The Regional Health Technology Assessment Centre (HTA-centrum) Surgical or endovascular intervention for aortic coarctation in adult native, residual or re-coarctation?
2014 The Regional Health Technology Assessment Centre (HTA-centrum) Intravenous immunoglobulin for post-polio syndrome
2014 The Regional Health Technology Assessment Centre (HTA-centrum) The use of teledermatology and teledermoscopy for referrals of patients with suspected skin cancer
2014 The Regional Health Technology Assessment Centre (HTA-centrum) Hemodialysis twice versus three times a week in patients with residual kidney function: quality of life, cardiovascular outcomes and mortality
2014 Andalusian Health Technology Assessment Area (AETSA) Digital tomosynthesis in breast cancer. Systematic Review
2014 Andalusian Health Technology Assessment Area (AETSA) Anti TNF alpha drugs for adults with moderate to severe non fistulizing active Chron's disease.
2014 Andalusian Health Technology Assessment Area (AETSA) Real-time 3D Transesophageal Echocardiography (RT-3D-TEE) versus 2D.
2014 Andalusian Health Technology Assessment Area (AETSA) Incompatible living donor kidney transplantation.
2014 Andalusian Health Technology Assessment Area (AETSA) Ranizumab and bevacizumab for the treatment of diabetic macular oedema.
2014 Andalusian Health Technology Assessment Area (AETSA) Lumbar total disc replacement effectiveness and safety in chronic low back pain.
2014 Andalusian Health Technology Assessment Area (AETSA) Efficacy and safety of kyphoplasty and vertebroplasty in osteoporotic vertebral compression fracture.
2014 Andalusian Health Technology Assessment Area (AETSA) Effectiveness and safety of interspinous devices
2014 Andalusian Health Technology Assessment Area (AETSA) Sacroiliac joint fusion. Open versus minimally invasive surgery.
2014 Basque Office for Health Technology Assessment (OSTEBA) [Geographical mental health map: geographical variation in psychosis and association with environmental factors]
2014 Basque Office for Health Technology Assessment (OSTEBA) [Relationship between use of cannabis and other drugs and psychiatric pathology in adolescents. A proposal of inpatient and outpatient mental health care in the Basque Health Service]
2014 Basque Office for Health Technology Assessment (OSTEBA) [Evaluation of care quality in the national health service towards severe childhood mental disorders. A study in infant/juvenile mental health services]
2014 Basque Office for Health Technology Assessment (OSTEBA) [The application of GRADE in the development of a CPG on childhood asthma]
2014 Basque Office for Health Technology Assessment (OSTEBA) [Using MitraClip® to repair mitral valve regurgitation]
2014 Basque Office for Health Technology Assessment (OSTEBA) [Intra-articular injection of platelet-rich plasma for treating knee arthrosis]
2014 Basque Office for Health Technology Assessment (OSTEBA) [Sperm washing in serodiscordant HIV couples for use in assisted human reproduction techniques]
2014 Basque Office for Health Technology Assessment (OSTEBA) [Sysadoas. Chondroprotective drugs in the treatment of arthritis]
2014 Basque Office for Health Technology Assessment (OSTEBA) [Measurement of the fraction of exhaled nitric oxide in the diagnosis and treatment of asthmatic children]
2014 Basque Office for Health Technology Assessment (OSTEBA) [New IMRT techniques for moving targets. An analysis of their safety and efficacy]
2014 Basque Office for Health Technology Assessment (OSTEBA) [An evaluation of intensity-modulated radiotherapy (IMRT)]
2014 Basque Office for Health Technology Assessment (OSTEBA) [Evaluation of the effectiveness of psychological intervention in the first psychotic episode by multidisciplinary treatment]
2014 Basque Office for Health Technology Assessment (OSTEBA) [Cryoablation in atrial fibrillation with Arctic Front catheter]
2014 Basque Office for Health Technology Assessment (OSTEBA) [Subcutaneous defibrillator]
2014 Basque Office for Health Technology Assessment (OSTEBA) [Bioresorbable peripheral stents]
2014 Basque Office for Health Technology Assessment (OSTEBA) [Magnetic resonance-compatible pacemakers]
2014 Basque Office for Health Technology Assessment (OSTEBA) [Retinal protection during eye surgery]
2014 Basque Office for Health Technology Assessment (OSTEBA) [Cost-effectiveness of percutaneous aortic valve replacement using prosthetic valve versus the standard surgical treatment]
2014 Basque Office for Health Technology Assessment (OSTEBA) [Use of radiography in diagnosing low back pain: systematic review]
2014 Basque Office for Health Technology Assessment (OSTEBA) [Diagnosis of gestational diabetes mellitus: evaluation of the new IADPSG criteria]
2014 Basque Office for Health Technology Assessment (OSTEBA) [Pilot study to identify and assess obsolete health technologies from emerging technologies identification databases]
2014 Basque Office for Health Technology Assessment (OSTEBA) [The development and piloting of a multidisciplinary collaborative program for the comprehensive care of patients diagnosed with heart failure (HF) – PROMIC]
2014 Adelaide Health Technology Assessment (AHTA) Intensive upper limb stroke rehabilitation
2014 Adelaide Health Technology Assessment (AHTA) Molecular testing for prostate cancer prognosis
2014 Andalusian Health Technology Assessment Area (AETSA) [Clinical practice guideline on intravenous therapy with temporary devices in adults]
2014 Andalusian Health Technology Assessment Area (AETSA) [Guide to clinical practice of care in pregnancy and puerperium]
2014 Andalusian Health Technology Assessment Area (AETSA) [Rapid review. Gender dysphoria. Diagnosis, treatment and health outcomes]
2014 Andalusian Health Technology Assessment Area (AETSA) [Summary of evidence for efficacy and safety of sofosbuvir in transplant patients with chronic hepatitis c]
2014 Andalusian Health Technology Assessment Area (AETSA) [Summary of evidence for efficacy and safety of sofosbuvir in patients with chronic hepatitis c waiting for liver transplant]
2014 Andalusian Health Technology Assessment Area (AETSA) [Summary of evidence for efficacy and safety of sofosbuvir in patients with chronic hepatitis c coinfected with human immunodeficiency virus]
2014 Andalusian Health Technology Assessment Area (AETSA) [Selection criteria for direct antiviral agents for patients with chronic hepatitis c in a severe clinical situation in the SSPA]
2014 Andalusian Health Technology Assessment Area (AETSA) [Updating of selection criteria for direct antiviral agents for patients with chronic hepatitis c in a severe clinical situation in the SSPA]
2014 Andalusian Health Technology Assessment Area (AETSA) [Communication strategies with children and adolescents in the hospital or primary care setting]
2014 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A13-33 (enzalutamide)]
2014 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Indicaterol/glycopyrronium - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2014 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Afatinib - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2014 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A13-37 (regorafenib)]
2014 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [User testing of IQWiG health information by socially disadvantaged people]
2014 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ipilimumab (new therapeutic indication) - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2014 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A13-35 (dabrafenib)]
2014 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Arthroscopy of the knee joint for gonarthrosis]
2014 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Palliation vs. curation - an attempt to clarify terms]
2014 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A13-44 (ipilimumab, new therapeutic indication)]
2014 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Trastuzumab emtansine - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2014 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Radium-223-dichloride - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2014 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Drug combination of emtricitabine, rilpivirine and tenofovir disoproxil (new therapeutic indication) - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2014 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Macitentan - Assessment according to §35a (para. 1., sentence 10) Social Code Book V (dossier assessment)]